Epilepsy
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Patients diagnosed with epilepsy; (2) Levetiracetam, lamotrigine, oxacepine or valproic acid have been taken regularly for more than 3 months; (3) Willing to participate in the experiment and sign the informed consent.
Exclusion criteria
Exclusion criteria: (1) Patients with serious diseases affecting the pahrmacology of antiseizure medications; (2) Patients concurrently taking other drugs that affect the pahrmacologyof antiseizure medications; (3) Patients who have irregular drug use in the past 3 months, with omissions, misadministration and other behaviors.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Concentrations of antiseizure medications;sensitivity;Accuracy;Specificity; | — |
Countries
China
Contacts
West China Hospital, Sichuan University